⌘K

Login Start Free

Home/Filings/4/0001567619-20-021288

4//SEC Filing

Kamal Fariborz 4

Accession 0001567619-20-021288

CIK 0001650648other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:40 PM ET

Size

4.7 KB

Accession

0001567619-20-021288

Insider Transaction Report

Form 4

Period: 2020-12-15

4D Molecular Therapeutics Inc.FDMT

President & COO

Transactions

Purchase
Common Stock
2020-12-15$23.00/sh+4,347$99,981→ 4,347 total

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

4D Molecular Therapeutics Inc.

CIK 0001650648

Entity typeother

Related Parties

1

filerCIK 0001834020

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 5:40 PM ET
Size: 4.7 KB

View on SEC.gov